Watanaboonyongcharoen, Phandee
https://orcid.org/0000-0002-8270-5308
Mayo Clinic
Chulalongkorn University
Citations 1
Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors
Holtan, Shernan G. , Khera, Nandita , Levine, John E. , Chai, Xiaoyu , Storer, Barry E. , Liu, Hien , Inamoto, Yoshihiro , Mayer, Sebastian , Arora, Mukta , Palmer, Jeanne , Lukez, Alexander , Arai, Sally , Lazaryan, Aleksandr , Newell, Laura F. , Krupski, Christa , Jagasia, Madan , Pusic, Iskra , Wood, William A. , Renteria, Anne S. , Yanik, Gregory A. , Ayuk, Francis , Holler, Ernst , Watanaboonyongcharoen, Phandee , Efebera, Yvonne A. , Ferrara, James L.M. , Weisdorf, Daniel J. , Lee, Stephanie J. , Pidala, Joseph, Chen, George L. , Flowers, Mary E.D. , Cutler, Corey S. , Hogan, William J. , Hexner, Elizabeth O. , Panoskaltsis‐Mortari, Angela , Weisdorf, Dan , Levine, John E , Holtan, Shernan , Lee, Stephanie J , Wood, William A
Blood | September 14, 2016 | Volume: 128 | Issue: 19 | Pages: 2350-2358
Key Points Under current treatment approaches, patients with LA GVHD have poor overall and failure-free survival. Levels of AREG are elevated in LA GVHD, and the AREG/EGF ratio is predictive of overall survival and nonrelapse mortality in LA GVHD.